Thorne HealthTech Updates FY 2023 Earnings Guidance
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
About 55% of Thorne HealthTech's investors are presently thinking to get in. The analysis of current outlook of investing in Thorne HealthTech suggests that some traders are interested regarding Thorne HealthTech's prospects. Thorne HealthTech's investing sentiment overview a quick insight into current market opportunities from investing in Thorne HealthTech. Many technical investors use Thorne HealthTech stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Thorne |
Thorne HealthTech updated its FY 2023 earnings guidance on Friday. The company provided earnings per share guidance of 0.25-0.31 for the period, compared to the consensus estimate of 0.31. The company issued revenue guidance of 280.00 million-290.00 million, compared to the consensus revenue estimate of 283.21 million. Analysts Set New
Read at thelincolnianonline.com
 |
Thorne HealthTech Fundamental Analysis
We analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earnings To Growth
Price To Earnings To Growth Comparative Analysis
Thorne HealthTech is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Thorne HealthTech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Thorne HealthTech stock to make a market-neutral strategy. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics with similar companies.
Peers
Thorne HealthTech Related Equities
| POST | Post Holdings | 0.42 | ||||
| NOMD | Nomad Foods | 0.18 | ||||
| ASBFF | Associated British | 0.00 | ||||
| JJSF | J J | 0.40 | ||||
| JBSS | John B | 0.60 | ||||
| NATR | Natures Sunshine | 0.86 | ||||
| LANC | Lancaster Colony | 1.02 | ||||
| CENT | Central Garden | 1.09 | ||||
| CENTA | Central Garden | 1.11 | ||||
| SMPL | Simply Good | 1.29 | ||||
| SENEA | Seneca Foods | 2.16 | ||||
| BRBR | Bellring Brands | 2.20 | ||||
| RGF | Real Good | 4.17 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |